Cargando…
Systemic DNA/RNA heteroduplex oligonucleotide administration for regulating the gene expression of dorsal root ganglion and sciatic nerve
Neuropathic pain, a heterogeneous condition, affects 7%–10% of the general population. To date, efficacious and safe therapeutic approaches remain limited. Antisense oligonucleotide (ASO) therapy has opened the door to treat spinal muscular atrophy, with many ongoing clinical studies determining its...
Autores principales: | Kaburagi, Hidetoshi, Nagata, Tetsuya, Enomoto, Mitsuhiro, Hirai, Takashi, Ohyagi, Masaki, Ihara, Kensuke, Yoshida-Tanaka, Kie, Ebihara, Satoe, Asada, Ken, Yokoyama, Hiroyuki, Okawa, Atsushi, Yokota, Takanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167871/ https://www.ncbi.nlm.nih.gov/pubmed/35694210 http://dx.doi.org/10.1016/j.omtn.2022.05.006 |
Ejemplares similares
-
DNA/RNA heteroduplex oligonucleotide technology for regulating lymphocytes in vivo
por: Ohyagi, Masaki, et al.
Publicado: (2021) -
Short DNA/RNA heteroduplex oligonucleotide interacting proteins are key regulators of target gene silencing
por: Asada, Ken, et al.
Publicado: (2021) -
Highly efficient silencing of microRNA by heteroduplex oligonucleotides
por: Yoshioka, Kotaro, et al.
Publicado: (2019) -
Modulation of blood-brain barrier function by a heteroduplex oligonucleotide in vivo
por: Kuwahara, Hiroya, et al.
Publicado: (2018) -
DNA Microarray Analysis of Differential Gene Expression in the Dorsal Root Ganglia of Four Different Neuropathic Pain Mouse Models
por: Yokoyama, Hiroyuki, et al.
Publicado: (2020)